Armenia Licensing under Decision No. 867: Storage and Distribution Obligations
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Armenia applies a licensing regime to medical device manufacturing and maintenance activities, with the rules established by Government Decision No. 867 of 2002-06-29; licensing and registration are two parallel regulatory tracks. The GRZAN conclusion: a foreign manufacturer that sets up a local entity in Armenia for manufacturing or maintenance must obtain a license separately; where the business is limited to import and distribution, the key obligations concentrate on verification of storage and transport conditions and on the triple pre-sale verification. Confusing the two tracks is a costly error: some companies assume a registration certificate covers everything, while others over-invest in licenses that their activity profile does not actually trigger.
2. Legal basis
| Regulation | Reference number | Publication date (effective date) | Provision |
|---|---|---|---|
| Licensing Rules and License Forms for Drug Manufacturing, Pharmacy Activities, Provision of Medical Care and Services by Organizations or Individual Entrepreneurs, Drug Wholesale, Medical Device Manufacturing and Medical Device Maintenance | Government of the Republic of Armenia Decision No. 867 of 2002-06-29 | 2002-06-29 | Full text of the licensing rules |
| Law of the Republic of Armenia on Medical Care and Services for the Population | No. ZR-42 of 1996-03-04 | Amended by No. ZR-504 of 2024-12-17 | Article 45 (licensing functions) |
| Law of the Republic of Armenia on Licensing | — | — | General licensing rules |
| General Requirements for the Safety and Effectiveness of Medical Devices and Requirements for Their Labeling and Operating Documentation | Eurasian Economic Commission Council Decision No. 27 of 2016-02-12 | 10 calendar days after entry into force of the Protocol | Article 5 (transport and storage) |
3. Expert insights
Insight 1: The licensing scope of Decision No. 867 spans drugs and medical devices. The rules established by the Decision cover drug manufacturing, pharmacy activities, provision of medical care and services by organizations or individual entrepreneurs, drug wholesale, medical device manufacturing and medical device maintenance, and prescribe the corresponding license forms. GRZAN note: the device-related licenses are manufacturing and maintenance; sale or distribution as such is not among the enumerated activities, but this does not mean distribution is obligation-free — the obligations at the distribution stage fall mainly on the transport and storage requirements of Decision No. 27 and on the three import-stage verifications.
Insight 2: Article 45 places licensing alongside registration and conformity assessment. Article 45 of the Law on Medical Care and Services provides that the powers of the authorized body in the field of medical device circulation include licensing of statutory business types, state registration and conformity assessment of imported medical devices. GRZAN note: when planning the entity structure, companies should assess separately whether an operating license is needed, whether state registration is needed and whether import conformity assessment is needed; the three can apply cumulatively to the same product and the same entity.
Insight 3: Storage and transport are regulated even though they require no license. Article 5 of Decision No. 27 requires that medical devices be designed, manufactured and packaged so that their performance and effectiveness are not impaired when transported and stored according to the instructions for use; the labeling must state any special storage and/or circulation conditions (where applicable). GRZAN note: in Armenian import practice, before starting sales the importer must verify the consistency of the accompanying document data with the actual device information, including compliance with the prescribed special storage and transport conditions (practical estimate). This makes execution records for cold chain, light protection and moisture control a focus of regulatory attention.
Insight 4: Importer eligibility is tied to the eligibility to apply for the import certificate. Decision No. 429-Ն provides that legal entities and individual entrepreneurs importing medical devices, or persons authorized by them may submit the import (conformity) certificate application. GRZAN note: this creates a de facto entity threshold — only a legal entity or individual entrepreneur actually engaged in the import, or its authorized person, can file. A foreign manufacturer without a local entity must rely on a local importer or its authorized person to complete the filing.
Insight 5: Maintenance activities are licensed on the same footing as manufacturing. Decision No. 867 places medical device maintenance and medical device manufacturing together within the licensing scope. GRZAN note: companies providing after-sales repair services, including repair centers set up in Armenia by manufacturers, need a separate assessment of licensing needs; this is a separate track from product registration, and holding a registration certificate does not exempt anyone from the maintenance license.
4. Practical recommendations
- Determine the activity type first: classify the operations into manufacturing, maintenance, import and distribution, and sales, and map the applicable licenses and obligations for each.
- Assess maintenance centers separately: for planned local repair or technical service operations, assess licensing needs under Decision No. 867.
- Keep records of storage and transport conditions: establish execution and monitoring records for temperature, humidity, light protection and moisture control, as evidence for the pre-sale verification.
- Confirm the importer eligibility: confirm the identity of the local legal entity or individual entrepreneur responsible for the import and issue the corresponding authorization documents.
- File licenses and registration separately: manage the operating license and the registration certificate as separate files, and never substitute one for the other.
5. Verification checklist
- □ The applicable licenses and obligations have been determined by activity type (manufacturing, maintenance, import and distribution, sales).
- □ It has been confirmed that local manufacturing or maintenance activities require a license under Decision No. 867.
- □ It has been confirmed that the filing entity for import is the legal entity or individual entrepreneur importing the devices, or a person authorized by it.
- □ Execution and monitoring records for special storage and transport conditions have been established.
- □ It has been verified under Article 5 of Decision No. 27 that packaging and transport methods do not impair performance and effectiveness.
- □ The operating license and the registration certificate have been filed and managed separately.
- □ The general rules of the Law of the Republic of Armenia on Licensing have been reviewed against the current text.
Regulatory information verified as of October 30, 2026.
This guide was prepared and translated by GRZAN. GRZAN provides end-to-end regulatory services for medical device manufacturers entering Armenia and the Eurasian Economic Union, including registration, licensing assessments, authorized representative services and distribution compliance support. For tailored advice on license-holder, import and fee matters, contact info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us